Discovering New Roles for CRISPR-Cas in Bacterial Pathogenesis
发现 CRISPR-Cas 在细菌发病机制中的新作用
基本信息
- 批准号:9349378
- 负责人:
- 金额:$ 39.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-25 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAffinity ChromatographyAnimal ModelBCAR1 geneBacteriaBacterial ProteinsBacteriophagesBiochemicalBioinformaticsBiological AssayBiological ModelsBiological ProcessCell physiologyCellsCleaved cellClustered Regularly Interspaced Short Palindromic RepeatsComplementComplexCoupledDNADefense MechanismsDiseaseElementsEngineeringEscherichia coliEukaryotic CellEvolutionGene Expression RegulationGenesGenetic TranscriptionGenomeGenomicsGrowthGuide RNAHumanHuman MicrobiomeImmune systemImmunizationInvadedInvestigationLeadMass Spectrum AnalysisMediatingMethodsMicrobeMicrobiologyNucleic Acid BindingNucleic AcidsOrganismOutcomePathogenesisPathogenicityPhysiologicalPlasmidsPlayPrevalenceProbabilityProblem SolvingProcessProductionProteinsProteomicsPseudomonas aeruginosaRNARecruitment ActivityResearchRoleSystemTechniquesTestingViralVirusVirus DiseasesVitronectinWorkbaseexperimental studygenome editinggut microbiomehelicasein vivoinhibitor/antagonistmembermicroorganismmutantnovelnovel therapeuticsnucleasepathogenpathogenic bacteriaprogramsprotein complexprotein functionpublic health relevanceribosome profilingtooltranscription factortranscriptomics
项目摘要
DESCRIPTION (provided by applicant): The CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated genes) system is a prokaryotic adaptive immune system that defends microbes from foreign invaders such as viruses. This immune system incorporates DNA from invading elements into the CRISPR locus, essentially generating an immunization record of past viral infection. The subsequent transcription and processing of the CRISPR locus generates small CRISPR RNAs (crRNAs) that are incorporated into a protein complex that mediates the destruction of nucleic acids based on sequence complementarity. Imperfect complementarity between the crRNA and its nucleic acid target can abrogate cleavage, but still recruit the protein complex in vivo. This recruitment can result in alternative
functions such as gene regulation, but the prevalence of these non-canonical CRISPR-Cas functions has not been investigated in detail. In fact, many pathogens and important human microbiome constituents possess CRISPR-Cas systems with no known role and CRISPR arrays with no predicted targets, raising a question as to what their biological functions are. The objective of this project is to identify endogenous bacterial proteins that may modulate CRISPR-Cas activity and discover and characterize novel CRISPR-Cas functions. This research is an extension of my graduate work, where I identified the first examples of CRISPR-Cas interacting proteins, which are a diverse group of inhibitors that directly interact with different CRISPR-Cas components. This suggests that more endogenous interactors remain to be identified. Together, the potential for nucleic acid binding in the absence of cleavage and the existence of CRISPR-Cas interacting proteins, suggests that there may be entire classes of bacterial proteins that can modulate or redirect CRISPR-Cas function. To broaden our understanding of the roles for CRISPR- Cas, I will utilize proteomic techniques to identify endogenous CRISPR-Cas interactors and characterize their physiological relevance. I will also conduct bio-informatic analyses to identify CRISPR-Cas systems that appear functional in pathogenic organisms and screen them for activity. Given the sequence diversity of the crRNAs generated by a single CRISPR-Cas system, both canonical (i.e. foreign genome cleavage) and non-canonical (i.e. gene regulation) functions could be mediated concurrently and functional assays will be developed to test these possibilities. The recent engineering of CRISPR-Cas systems to provide genome editing and regulatory tools in eukaryotic cells (where these systems do not naturally exist) perfectly exemplify the possibilities that are intrinsic to an RNA-guided system. The possibility that bacteria naturally possess similar functions (i.e. CRISPR-Cas-mediated recruitment of a transcription factor) has not been investigated. Assessing the roles of these systems in many different organisms will enhance our understanding of not only CRISPR-Cas systems, but also of how bacterial pathogens defend their genomes and regulate vital cell processes.
描述(由申请人提供):CRISPR-Cas(规则间隔短回文重复序列和CRISPR相关基因)系统是一种原核适应性免疫系统,可防御微生物免受外来入侵者(如病毒)的侵害。这种免疫系统将来自入侵元件的DNA整合到CRISPR基因座中,基本上产生了过去病毒感染的免疫记录。CRISPR基因座的后续转录和加工产生小CRISPR RNA(crRNA),其被掺入基于序列互补性介导核酸破坏的蛋白质复合物中。crRNA与其核酸靶标之间的不完全互补性可消除切割,但仍在体内募集蛋白质复合物。这种招聘可能会导致替代
CRISPR-Cas的功能,如基因调控,但这些非典型的CRISPR-Cas功能的流行还没有被详细研究。事实上,许多病原体和重要的人类微生物组成分都拥有没有已知作用的CRISPR-Cas系统和没有预测靶点的CRISPR阵列,这就提出了一个关于它们的生物学功能是什么的问题。该项目的目的是鉴定可能调节CRISPR-Cas活性的内源性细菌蛋白,并发现和表征新的CRISPR-Cas功能。这项研究是我的研究生工作的延伸,在那里我确定了CRISPR-Cas相互作用蛋白的第一个例子,这是一组直接与不同CRISPR-Cas组分相互作用的不同抑制剂。这表明,更多的内源性相互作用者仍有待确定。总之,在不存在切割和存在CRISPR-Cas相互作用蛋白的情况下核酸结合的可能性表明可能存在可以调节或重定向CRISPR-Cas功能的整类细菌蛋白。为了扩大我们对CRISPR-Cas作用的理解,我将利用蛋白质组学技术来鉴定内源性CRISPR-Cas相互作用物并表征其生理相关性。我还将进行生物信息学分析,以确定在病原生物中发挥作用的CRISPR-Cas系统,并筛选它们的活性。考虑到由单个CRISPR-Cas系统产生的crRNA的序列多样性,可以同时介导规范(即外源基因组切割)和非规范(即基因调控)功能,并且将开发功能测定来测试这些可能性。最近对CRISPR-Cas系统进行工程改造,以在真核细胞中提供基因组编辑和调控工具(其中这些系统并不天然存在),完美地证明了RNA引导系统固有的可能性。细菌天然具有类似功能(即CRISPR-Cas介导的转录因子募集)的可能性尚未研究。评估这些系统在许多不同生物体中的作用不仅将增强我们对CRISPR-Cas系统的理解,还将增强我们对细菌病原体如何保护其基因组和调节重要细胞过程的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Bondy-Denomy其他文献
Joseph Bondy-Denomy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Bondy-Denomy', 18)}}的其他基金
Investigating the mechanisms that make jumbophages impervious to bacterial immune systems
研究使巨噬细胞不受细菌免疫系统影响的机制
- 批准号:
10503219 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Identifying the mechanism of bacteriophage detection by cyclic-oligonucleotide signaling systems
通过环状寡核苷酸信号系统识别噬菌体检测机制
- 批准号:
10432910 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Identifying the mechanism of bacteriophage detection by cyclic-oligonucleotide signaling systems
通过环状寡核苷酸信号系统识别噬菌体检测机制
- 批准号:
10550270 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Genetic and Proteomic Approaches to Reveal Bacterial Vulnerabilities to Phage Predation
揭示细菌对噬菌体捕食的脆弱性的遗传和蛋白质组学方法
- 批准号:
10625434 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Investigating the mechanisms that make jumbophages impervious to bacterial immune systems
研究使巨噬细胞不受细菌免疫系统影响的机制
- 批准号:
10663359 - 财政年份:2022
- 资助金额:
$ 39.63万 - 项目类别:
Uncovering the mechanism and role of a widespread anti-CRISPR-Cas9 protein
揭示广泛存在的抗 CRISPR-Cas9 蛋白的机制和作用
- 批准号:
10365999 - 财政年份:2018
- 资助金额:
$ 39.63万 - 项目类别:
Uncovering the mechanism and role of a widespread anti-CRISPR-Cas9 protein
揭示广泛存在的抗 CRISPR-Cas9 蛋白的机制和作用
- 批准号:
9901545 - 财政年份:2018
- 资助金额:
$ 39.63万 - 项目类别:
Discovering New Roles for CRISPR-Cas in Bacterial Pathogenesis
发现 CRISPR-Cas 在细菌发病机制中的新作用
- 批准号:
9150686 - 财政年份:2015
- 资助金额:
$ 39.63万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 39.63万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 39.63万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 39.63万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 39.63万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 39.63万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 39.63万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 39.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 39.63万 - 项目类别:
Collaborative Research and Development Grants